Ngokwezibalo zezokwelapha, abangaphezu kwesigamu sabo bonke besifazane emhlabeni emva kweminyaka engama-35 basengozini yokuthuthukisa isifo senhliziyo noma kakade babhekene nezifo ezinjalo. Ukuze uphathe izifo zenhliziyo, izazi ze-cardiologists zivame ukubeka i-Riboxin - izinkomba zokusebenzisa le mithi zihlanganisa umonakalo omkhulu we-myocardial nezinye izifo ezihlobene ne-oksijini yindlala yamathishu kanye nezitho zangaphakathi.
Izinkomba zokusebenzisa i-Riboxin ngaphakathi
Ifomu le-liquid lensiza liyatholakala kuma-ampoules angu-20 ml. Kulawa, i-1 ml ibalwe isithako esisebenzayo - i-inosine.
Izinkomba eziyinhloko zokusetshenziswa kwezijovo zeRiboxin zibangelwa ikhono lezinto ezicatshangelwayo ukugqugquzela izinqubo zemithi emzimbeni. I-Inosine iveza imiphumela elandelayo:
- i-antiarrhythmic;
- i-antihypoxic;
- ukuthuthukisa ukujikeleza kwegazi emithanjeni ye-coronary;
- ukulinganisela kwamandla we-myocardium;
- ukuvuselelwa kwe-glucose metabolism;
- ukuvinjelwa kwezinsolo ezingenayo i-intraoperative ye-ischemia;
- ukujwayelekile kwezimo zokuphefumula kwezicubu;
- ukuvuselela kwe-nucleotide synthesis;
- ukwanda emandleni enkontileka yenhliziyo kanye nevolumu yokuvuthwa;
- Ukwandisa ukuvuselelwa kwezicubu;
- ukuphumuza kwe-myocardium ku-diastole.
Ngenxa yokuthi iningi elikhulu lemiphumela emihle, izinkomba zokusebenzisa i-Riboxin kuma-ampoules zihlanganisa okulandelayo:
- ischemic isifo senhliziyo;
- ukudluliselwa kwe- infarction ye-myocardial ;
- i-dystrophy ye-myocardial ngemuva kwezifo ezithathelwanayo;
- ukuphazamiseka kwesigqi senhliziyo, kuhlanganise nalabo asethuthukile ngemuva kokusetshenziswa kwe-glycosides;
- i-cirrhosis yesibindi;
- isifo sofuba semvelaphi ehlukahlukene;
- i-fatty foy dystrophy.
Ngaphezu kwalokho, ukujova izidakamizwa kusetshenziswa njengesidakamizwa sokuvikelwa kwemithi ngesikhathi sokuhlinzeka ngezinhlinzeko zokuhlinza izinso ezikude, uma kudingeka ukuba ususe okwesikhashana ukusakaza.
Izinkomba zokusebenzisa i-Riboxin capsules ngokwemiyalo
Enye indlela yokukhululwa kwezidakamizwa ezichazwe kunqunywe ngesikhathi sezinkinga ezingekho, ukuze uthole ukwelashwa okuhleliwe ngaphandle komtholampilo esibhedlela.
I-Riboxin ngendlela yama-capsules isetshenziselwa izifo nezimo ezinjalo:
- zitholakale, izintuthwane zenhliziyo ezindala;
- ukuphuza ngokweqile;
- ischemic isifo senhliziyo;
- izinguquko ezinamahloni ezinhlobonhlobo ze-myocardium ngemuva kokususwa kwe-endocrine, izifo ezithathelwanayo, kanye nokuzikhandla ngokweqile ngokomzimba;
- ukubola kwesibindi kwesibindi;
- ukwelashwa ngemuva kokuhlukunyezwa kwe-myocardial yangaphambili;
- ukuphazamiseka kwenhliziyo;
- i-myocardial dystrophy;
- ukuvimbela ukuthuthukiswa kwe-leukopenia ngesikhathi se-radiation irradiation;
- i-myocarditis;
- i-cirrhosis yesibindi;
- i-hepatitis, kuhlanganise nohlobo lwezokwelapha nezidakamizwa.
Izinkomba zokusebenzisa amaphilisi we-Riboxin
Futhi, ukulungiswa kuvezwe kwifomu yethebhulethi, umthamo wesithako esisebenzayo kulokhu kufana nokuhlushwa kwe-inosine kuma-capsules futhi ngu-200 mg. Kunezinhlobonhlobo eziningi zamaphilisi e-Riboxin - LekT, Darnitsa, Ferein, UVI, Vero, PNITIA nabanye. Ayehlukile, amagama anqunywa yinkampani eveza imithi.
Amathebulethi anconywa ezimweni ezilandelayo:
- ukwelashwa okuyinkimbinkimbi yesifo senhliziyo ischemic;
- isikhathi sokutakula ngemva kokuhlukunyezwa kwe-myocardial;
- ukuphazamiseka kwengoma yenhliziyo ngokumelene nesizinda se-glycosides;
- urocoppororphyria;
- i-cirrhosis, ukuwohloka kwamafutha kwesibindi ;
- isifo sofuba.
Kumele uqaphele ukuthi izinkomba zokusebenzisa i-Riboxin LekT azifaki izimo ku-arrhythmia nakwamanye ama-arrhythmiya enhliziyo uma kungabangelwa ukugqwala kwe-glycosidic.